{{Drugbox
| IUPAC_name    = [2-(5-Bromo-1''H''-indol-3-yl)ethyl]dimethylamine
| image         = 5-Bromo-DMT.svg
| width         = 220

<!--Clinical data-->
| tradename                =
| routes_of_administration =
| legal_UK = Class A
| legal_status =

<!--Identifiers-->
| CAS_number = 17274-65-6
| ATC_suffix     =
| PubChem        = 360252
| ChemSpiderID = 319812

<!--Chemical data-->
| C=12 | H=15 | N=2 | Br=1
| smiles = BrC2=CC=C1[NH]C=C(C1=C2)CCN(C)C
| StdInChI = 1S/C12H15BrN2/c1-15(2)6-5-9-8-14-12-4-3-10(13)7-11(9)12/h3-4,7-8,14H,5-6H2,1-2H3
| StdInChIKey = ATEYZYQLBQUZJE-UHFFFAOYSA-N
}}

'''5-Bromo-DMT''' ('''5-bromo-''N'',''N''-dimethyltryptamine''') is a [[psychedelic drug]] of the [[tryptamine]] class and a [[bromide|brominated]] [[indole]] [[alkaloid]] that was found in the marine [[invertebrate]]s ''Smenospongia aurea'' and ''Smenospongia echina'', as well as in ''Verongula rigida'' (0.00142% dry weight) alongside 5,6-Dibromo-DMT (0.35% dry weight) and seven other alkaloids.<ref>{{cite web | url=http://www.google.com/patents/US20120029010 | title=Patent US 20120029010 - Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter | date=2 February 2012 | accessdate=21 October 2015 | author=Mark T. Hamann | author2=Anna J. Kochanowska | author3=Abir El-Alfy| author4=Rae R. Matsumoto | author5=Angelo Boujos}}</ref><ref>{{cite journal | title=Bioactive Indole Derivatives from the South Pacific Marine Sponges Rhopaloeides odorabile and Hyrtios sp. | author=Arlette Longeon | author2=Brent R. Copp | author3=Elodie Quévrain| author4=Mélanie Roué | author5=Betty Kientz| author6=Thierry Cresteil | author7=Sylvain Petek| author8=Cécile Debitus | author9=Marie-Lise Bourguet-Kondracki | journal=marine drugs | date=May 2011 | volume=9 | issue=5 | pages=879–888 | doi=10.3390/md9050879 | pmid=21673896 | pmc=3111189}}</ref><ref>{{cite journal | url=http://pubs.acs.org/doi/abs/10.1021/np010471e | title=New Antiinfective and Human 5-HT2 Receptor Binding Natural and Semisynthetic Compounds from the Jamaican Sponge Smenospongia aurea | author=Jin-Feng Hu | author2=John A. Schetz | author3=Michelle Kelly| author4=Jiang-Nan Peng | author5=Kenny K. H. Ang| author6=Horst Flotow | author7=Chung Yan Leong| author8=Siew Bee Ng | author9=Antony D. Buss| author10=Scott P. Wilkins | author11=Mark T. Hamann | journal=Journal of Natural Products | date=March 2002 | volume=65 | issue=4 | pages=476–480 | doi=10.1021/np010471e | pmid=11975483}}</ref><ref>{{cite journal | url=http://pubs.acs.org/doi/abs/10.1021/jo01296a019 | title=Some metabolites of the marine sponges Smenospongia aurea and Smenospongia (.ident.Polyfibrospongia) echina | author=Peter Djura | author2=Donald B. Stierle | author3=Brian Sullivan | author4=D. John Faulkner | author5=Edward V. Arnold | author6=Jon Clardy | journal=Journal of Organic Chemistry | date=April 1980 | volume=45 | issue=8 | pages=1435–1441 | doi=10.1021/jo01296a019}}</ref> It is the 5-[[bromine|bromo]] [[derivative (chemistry)|derivative]] of [[N,N-Dimethyltryptamine|DMT]], a psychedelic found in many plants and animals.

5-Bromo-DMT has a pEC50 value of 5.51 for the [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]].<ref>{{cite web | url=http://epub.uni-regensburg.de/13400/ | title=5-Carboxamidotryptamin-Derivate als Liganden für 5-HT<sub>7</sub>- und 5-HT<sub>2A</sub>-Rezeptoren: Synthese und In-vitro-Pharmakologie | publisher=Universität Regensburg | date=10 March 2015 | accessdate=21 October 2015 | author=Thorsten Matzdorf | language=German}}</ref>

Animal studies on 5-Bromo-DMT showed that it produces effects suggestive of [[sedative]] and [[antidepressant]] activity and caused significant reduction of locomotor activity in the rodent FST model.<ref>{{cite journal | url=http://pubs.acs.org/doi/abs/10.1021/np070371u | title=Secondary Metabolites from Three Florida Sponges with Antidepressant Activity | author=Anna J. Kochanowska | author2=Karumanchi V. Rao | author3=Suzanne Childress| author4=Abir El-Alfy | author5=Rae R. Matsumoto| author6=Michelle Kelly | author7=Gina S. Stewart| author8=Kenneth J. Sufka | author9=Mark T. Hamann | journal=Journal of Natural Products | date=January 2008 | volume=71 | issue=2 | pages=186–189 | doi=10.1021/np070371u | pmid=18217716}}</ref>

5-Bromo-DMT was reported to be psychoactive at 20–50&nbsp;mg via vaporization with mild psychedelic-like activity.<ref>{{cite web | url=https://www.vice.com/read/sea-dmt-000481-v20n3 | title=Sea DMT: God Molecule or Barnacle Repellent? | publisher=Vice | date=26 March 2013 | accessdate=21 October 2015 | author=Hamilton Morris | author2=Jason Wallach}}</ref>

== See also ==
* [[5-Chloro-αMT]]
* [[5-Fluoro-AMT]]
* [[5-Fluoro-DMT]]
* [[Convolutindole A]]
* [[Desformylflustrabromine]]
* [[Plakohypaphorine]]

== References ==
{{reflist}}

{{Hallucinogens}}
{{Serotonergics}}
{{Tryptamines}}

{{DEFAULTSORT:Bromo-DMT, 5-}}
[[Category:Bromoarenes]]
[[Category:Designer drugs]]
[[Category:Halogen-containing alkaloids]]
[[Category:Psychedelic tryptamines]]
[[Category:Serotonin receptor agonists]]
[[Category:Tryptamine alkaloids]]